As with our previous report demonstrating that sarcolemmal AQP4 is a target of IgG in patients with NMO [19], these observations further expand the cellular repertoire of NMO IgG targets beyond the archetypal astrocyte. The gene discussed is AQP4; the disease is neuromyelitis optica.